Quantum Genomics SA - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Quantum Genomics SA (ALQGC) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

€3.75 Million

≈ $4.38 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2023)

This chart shows how Quantum Genomics SA's Asset Resilience Ratio has changed over time. Check ALQGC strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Quantum Genomics SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Quantum Genomics SA market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€0.00	0%
Total Liquid Assets	€0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Quantum Genomics SA maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Quantum Genomics SA Industry Peers by Asset Resilience Ratio

Compare Quantum Genomics SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Sk Biopharmaceuticals Co Ltd KO:326030	Biotechnology	0.14%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Theravance Biopharma Inc F:0TB	Biotechnology	37.29%

Annual Asset Resilience Ratio for Quantum Genomics SA (2012–2023)

The table below shows the annual Asset Resilience Ratio data for Quantum Genomics SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.29%	€-11.00K ≈ $-12.86K	€3.75 Million ≈ $4.38 Million	-0.43pp
2022-12-31	0.14%	€32.31K ≈ $37.77K	€23.66 Million ≈ $27.66 Million	-24.66pp
2021-12-31	24.80%	€5.27 Million ≈ $6.16 Million	€21.24 Million ≈ $24.83 Million	+8.67pp
2020-12-31	16.13%	€5.29 Million ≈ $6.18 Million	€32.80 Million ≈ $38.35 Million	-19.09pp
2019-12-31	35.21%	€5.20 Million ≈ $6.08 Million	€14.78 Million ≈ $17.28 Million	+35.13pp
2018-12-31	0.09%	€16.04K ≈ $18.76K	€18.48 Million ≈ $21.61 Million	-71.79pp
2017-12-31	71.88%	€10.00 Million ≈ $11.69 Million	€13.92 Million ≈ $16.27 Million	+32.98pp
2015-12-31	38.90%	€4.10 Million ≈ $4.79 Million	€10.54 Million ≈ $12.32 Million	+38.90pp
2013-12-31	0.00%	€-1.00 ≈ $-1.17	€1.69 Million ≈ $1.98 Million	-0.15pp
2012-12-31	0.15%	€1.59K ≈ $1.86K	€1.06 Million ≈ $1.24 Million	--

pp = percentage points

About Quantum Genomics SA

PA:ALQGC France Biotechnology

Market Cap

$5.87 Million

€5.02 Million EUR

Market Cap Rank

#28554 Global

#514 in France

Share Price

€0.07

Change (1 day)

+0.00%

52-Week Range

€0.07 - €0.07

All Time High

€9.73